SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-211865
Filing Date
2022-08-04
Accepted
2022-08-04 08:16:04
Documents
16
Period of Report
2022-08-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d391452d8k.htm   iXBRL 8-K 49294
2 EX-2.1 d391452dex21.htm EX-2.1 438272
3 EX-99.1 d391452dex991.htm EX-99.1 33683
7 GRAPHIC g346334g0804124456891.jpg GRAPHIC 4469
8 GRAPHIC g346334g0804124457094.jpg GRAPHIC 3035
  Complete submission text file 0001193125-22-211865.txt   777565

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20220803.xsd EX-101.SCH 2871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20220803_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20220803_pre.xml EX-101.PRE 11271
10 EXTRACTED XBRL INSTANCE DOCUMENT d391452d8k_htm.xml XML 3349
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 221134846
SIC: 2834 Pharmaceutical Preparations